2024 Q2 Form 10-K Financial Statement

#000185263324000036 Filed on June 28, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 2023
Revenue $36.20M $118.7M $111.3M
YoY Change 849817.82% 6.7%
Cost Of Revenue $6.564M $20.30M $18.97M
YoY Change 7.0%
Gross Profit $29.63M $98.43M $92.31M
YoY Change 6.63%
Gross Profit Margin 81.87% 82.9% 82.95%
Selling, General & Admin $23.64M $85.90M $72.75M
YoY Change 2807.4% 18.07% 8189.73%
% of Gross Profit 79.78% 87.27% 78.82%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.933M $8.350M $8.086M
YoY Change 3.26%
% of Gross Profit 9.9% 8.48% 8.76%
Operating Expenses $40.28M $120.2M $103.7M
YoY Change 1155.76% 15.96% 5811.67%
Operating Profit -$10.65M -$21.79M -$13.73M
YoY Change 231.99% 58.68% 682.87%
Interest Expense $1.838M $11.74M $1.946M
YoY Change 56.03% 503.34% -50.6%
% of Operating Profit
Other Income/Expense, Net $140.0K $140.0K -$13.00K
YoY Change -104.46% -1176.92% -100.07%
Pretax Income -$8.672M -$6.753M -$7.333M
YoY Change 36.67% -7.91% -144.31%
Income Tax $36.00K $36.00K $192.0K
% Of Pretax Income
Net Earnings -$8.708M -$6.789M -$7.525M
YoY Change 32.29% -9.78% -147.74%
Net Earnings / Revenue -24.06% -5.72% -6.76%
Basic Earnings Per Share -$0.41 -$0.66
Diluted Earnings Per Share -$0.21 -$0.41 -$0.66
COMMON SHARES
Basic Shares Outstanding 22.32M shares 11.48M shares
Diluted Shares Outstanding 22.32M shares 11.48M shares

Balance Sheet

Concept 2024 Q2 2024 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.17M $13.17M $8.436M
YoY Change 3573.3% 56.13% 1551.24%
Cash & Equivalents $13.17M $13.17M $8.436M
Short-Term Investments
Other Short-Term Assets $2.101M $2.101M $577.0K
YoY Change 996.73% 264.12% 125.25%
Inventory $949.0K $949.0K $802.0K
Prepaid Expenses
Receivables $1.137M $1.137M $1.310M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $17.36M $17.36M $11.13M
YoY Change 3055.24% 56.03% 1350.36%
LONG-TERM ASSETS
Property, Plant & Equipment $80.02M $146.4M $118.4M
YoY Change 27.33% 23.58%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.586M $3.586M $1.356M
YoY Change -91.5% 164.45% -99.46%
Total Long-Term Assets $150.0M $150.0M $119.8M
YoY Change 255.44% 25.18% -52.14%
TOTAL ASSETS
Total Short-Term Assets $17.36M $17.36M $11.13M
Total Long-Term Assets $150.0M $150.0M $119.8M
Total Assets $167.3M $167.3M $130.9M
YoY Change 291.48% 27.8% -47.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $22.71M $22.71M $19.31M
YoY Change 8882.98% 17.62% 7783.13%
Accrued Expenses $28.31M $28.31M $31.44M
YoY Change 1011.62% -9.95% 16150.45%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $4.818M $4.818M $1.044M
YoY Change 361.49% 361.49%
Total Short-Term Liabilities $69.88M $69.88M $61.98M
YoY Change 1153.56% 12.75% 4972.14%
LONG-TERM LIABILITIES
Long-Term Debt $70.68M $70.68M $36.21M
YoY Change 95.18%
Other Long-Term Liabilities $1.386M $95.92M $94.27M
YoY Change -84.43% 1.75% 818.8%
Total Long-Term Liabilities $72.06M $166.6M $130.5M
YoY Change 709.79% 27.68% 1171.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $69.88M $69.88M $61.98M
Total Long-Term Liabilities $72.06M $166.6M $130.5M
Total Liabilities $236.5M $236.5M $192.5M
YoY Change 1533.85% 22.87% 1576.19%
SHAREHOLDERS EQUITY
Retained Earnings -$125.8M
YoY Change 803.34%
Common Stock $4.000K
YoY Change 300.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$69.16M -$69.16M -$61.53M
YoY Change
Total Liabilities & Shareholders Equity $167.3M $167.3M $130.9M
YoY Change 291.48% 27.8% -47.86%

Cashflow Statement

Concept 2024 Q2 2024 2023
OPERATING ACTIVITIES
Net Income -$8.708M -$6.789M -$7.525M
YoY Change 32.29% -9.78% -147.74%
Depreciation, Depletion And Amortization $2.933M $8.350M $8.086M
YoY Change 3.26%
Cash From Operating Activities -$16.86M -$32.68M -$12.04M
YoY Change 767.22% 171.45% 723.9%
INVESTING ACTIVITIES
Capital Expenditures $7.357M $22.13M $12.99M
YoY Change 70.39%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$7.357M -$22.13M -$12.99M
YoY Change -103.5% 70.39% -94.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $1.429M $6.144M
YoY Change -76.74%
Cash From Financing Activities -2.245M $59.55M $24.56M
YoY Change -98.93% 142.49% -90.11%
NET CHANGE
Cash From Operating Activities -16.86M -$32.68M -$12.04M
Cash From Investing Activities -7.357M -$22.13M -$12.99M
Cash From Financing Activities -2.245M $59.55M $24.56M
Net Change In Cash -26.47M $4.735M -$471.0K
YoY Change 1613.44% -1105.31% -203.1%
FREE CASH FLOW
Cash From Operating Activities -$16.86M -$32.68M -$12.04M
Capital Expenditures $7.357M $22.13M $12.99M
Free Cash Flow -$24.22M -$54.81M -$25.03M
YoY Change 119.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001852633
CY2024 dei Amendment Flag
AmendmentFlag
false
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-04-28
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-28
CY2024 dei Document Transition Report
DocumentTransitionReport
false
CY2024 dei Entity File Number
EntityFileNumber
001-41236
CY2024 dei Entity Registrant Name
EntityRegistrantName
Pinstripes Holdings, Inc.
CY2024 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-2556699
CY2024 dei Entity Address Address Line1
EntityAddressAddressLine1
1150 Willow Road
CY2024 dei Entity Address City Or Town
EntityAddressCityOrTown
Northbrook
CY2024 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2024 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60062
CY2024 dei City Area Code
CityAreaCode
847
CY2024 dei Local Phone Number
LocalPhoneNumber
480-2323
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
true
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2024 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2024 dei Auditor Firm
AuditorFirmId
248
CY2023 dei Auditor Firm
AuditorFirmId
42
CY2024 dei Auditor Name
AuditorName
GRANT THORNTON LLP
CY2024 dei Auditor Location
AuditorLocation
Chicago, Illinois
CY2023 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2023 dei Auditor Location
AuditorLocation
Chicago, Illinois
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13171000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8436000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1137000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1310000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
949000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
802000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2101000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
577000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
17358000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
11125000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
80015000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
62842000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
66362000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
55604000 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3586000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1356000 usd
CY2024Q2 us-gaap Assets
Assets
167321000 usd
CY2023Q2 us-gaap Assets
Assets
130927000 usd
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
4818000 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1044000 usd
CY2024Q2 pnst Accrued Occupancy Current
AccruedOccupancyCurrent
6508000 usd
CY2023Q2 pnst Accrued Occupancy Current
AccruedOccupancyCurrent
14940000 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6546000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6688000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
15259000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10727000 usd
CY2024Q2 pnst Warrant Liability Current
WarrantLiabilityCurrent
5411000 usd
CY2023Q2 pnst Warrant Liability Current
WarrantLiabilityCurrent
1925000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
69881000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
61978000 usd
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
70677000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
36211000 usd
CY2024Q2 pnst Accrued Occupancy Noncurrent
AccruedOccupancyNoncurrent
277000 usd
CY2023Q2 pnst Accrued Occupancy Noncurrent
AccruedOccupancyNoncurrent
2020000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
94256000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
91398000 usd
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1386000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
850000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
236477000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
192457000 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2023Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
53468000 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
430000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
430000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40087785 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40087785 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11422476 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11422476 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
4000 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
56623000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3794000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-125783000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-118793000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-69156000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-114998000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
167321000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
130927000 usd
CY2024 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
118724000 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
111273000 usd
CY2024 us-gaap Labor And Related Expense
LaborAndRelatedExpense
44044000 usd
CY2023 us-gaap Labor And Related Expense
LaborAndRelatedExpense
40415000 usd
CY2023 us-gaap Occupancy Net
OccupancyNet
18375000 usd
CY2024 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19989000 usd
CY2024 us-gaap Depreciation
Depreciation
8350000 usd
CY2023 us-gaap Depreciation
Depreciation
8086000 usd
CY2024 us-gaap Pre Opening Costs
PreOpeningCosts
8889000 usd
CY2023 us-gaap Pre Opening Costs
PreOpeningCosts
4935000 usd
CY2024 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
2363000 usd
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
-21785000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-13729000 usd
CY2024 us-gaap Interest Expense
InterestExpense
11741000 usd
CY2023 us-gaap Interest Expense
InterestExpense
1946000 usd
CY2024 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-26633000 usd
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
CY2024 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
140000 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-13000 usd
CY2024 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
8355000 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6753000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7333000 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
36000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
192000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-6789000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-7525000 usd
CY2024 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
2301000 usd
CY2023 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0 usd
CY2024 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9090000 usd
CY2024 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-9090000 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7525000 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-7525000 usd
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.66
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.66
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22317755 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11480322 shares
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22317755 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11480322 shares
CY2022Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
18644339 shares
CY2022Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
52218000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-109556000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-7525000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1722000 usd
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
66000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
295000 usd
CY2024 us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
878000 usd
CY2024 us-gaap Dividends Preferred Stock
DividendsPreferredStock
878000 usd
CY2024 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
1423000 usd
CY2024 us-gaap Preferred Stock Convertible Down Round Feature Increase Decrease In Equity Amount1
PreferredStockConvertibleDownRoundFeatureIncreaseDecreaseInEquityAmount1
-1423000 usd
CY2024 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1178000 usd
CY2024 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
173000 usd
CY2024 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-894000 usd
CY2024 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2203000 usd
CY2024 pnst Temporary Equity Conversion Of Dividends
TemporaryEquityConversionOfDividends
878000 usd
CY2024 pnst Dividends Conversion Of Dividends
DividendsConversionOfDividends
878000 usd
CY2024 pnst Temporary Equity Stock Issued During Period Shares Conversion Of Convertible Securities
TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
20989710 shares
CY2024 pnst Temporary Equity Stock Issued During Period Value Conversion Of Convertible Securities
TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities
74734000 usd
CY2024 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 usd
CY2024 pnst Adjustments To Additional Paid In Capital Transfer Of Warrants
AdjustmentsToAdditionalPaidInCapitalTransferOfWarrants
29824000 usd
CY2024 pnst Adjustments To Additional Paid In Capital Recapitalization Transaction Costs
AdjustmentsToAdditionalPaidInCapitalRecapitalizationTransactionCosts
23958000 usd
pnst Stock Issued During Period Value Settlement Of Unpaid Interest
StockIssuedDuringPeriodValueSettlementOfUnpaidInterest
138000 usd
us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-178000 usd
CY2024Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2024Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-69156000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-6789000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-7525000 usd
CY2024 pnst Gain Loss On Lease Modification
GainLossOnLeaseModification
3281000 usd
CY2023 pnst Gain Loss On Lease Modification
GainLossOnLeaseModification
0 usd
CY2024 us-gaap Depreciation
Depreciation
8350000 usd
CY2023 us-gaap Depreciation
Depreciation
8086000 usd
CY2024 pnst Operating Lease Noncash Expense
OperatingLeaseNoncashExpense
5594000 usd
CY2023 pnst Operating Lease Noncash Expense
OperatingLeaseNoncashExpense
5252000 usd
CY2024 us-gaap Paid In Kind Interest
PaidInKindInterest
3430000 usd
CY2023 us-gaap Paid In Kind Interest
PaidInKindInterest
0 usd
CY2024 pnst Tenant Improvements Noncash Expense
TenantImprovementsNoncashExpense
-42000 usd
CY2023 pnst Tenant Improvements Noncash Expense
TenantImprovementsNoncashExpense
7727000 usd
CY2024 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1178000 usd
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
295000 usd
CY2024 pnst Fair Value Adjustment Of Warrants And Other
FairValueAdjustmentOfWarrantsAndOther
-26633000 usd
CY2023 pnst Fair Value Adjustment Of Warrants And Other
FairValueAdjustmentOfWarrantsAndOther
0 usd
CY2024 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
8355000 usd
CY2024 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1951000 usd
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
246000 usd
CY2024 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
2363000 usd
CY2024 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-173000 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
431000 usd
CY2024 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
147000 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
99000 usd
CY2024 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1034000 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
250000 usd
CY2024 pnst Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
5548000 usd
CY2023 pnst Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
0 usd
CY2024 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
3586000 usd
CY2023 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
0 usd
CY2024 pnst Increase Decrease In Occupancy Net
IncreaseDecreaseInOccupancyNet
-5556000 usd
CY2023 pnst Increase Decrease In Occupancy Net
IncreaseDecreaseInOccupancyNet
-3595000 usd
CY2024 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
80000 usd
CY2023 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-662000 usd
CY2024 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-6162000 usd
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-7632000 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-32682000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12040000 usd
CY2024 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22128000 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12987000 usd
CY2024 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-22128000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12987000 usd
CY2024 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
66000 usd
CY2024 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1000 usd
CY2023 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
CY2024 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
24592000 usd
CY2023 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
3758000 usd
CY2024 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
19843000 usd
CY2023 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
200000 usd
CY2024 pnst Payments For Business Acquisition Transaction Costs
PaymentsForBusinessAcquisitionTransactionCosts
23864000 usd
CY2023 pnst Payments For Business Acquisition Transaction Costs
PaymentsForBusinessAcquisitionTransactionCosts
0 usd
CY2024 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1429000 usd
CY2023 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
6144000 usd
CY2024 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1012000 usd
CY2023 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
CY2024 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
773000 usd
CY2023 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2304000 usd
CY2024 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0 usd
CY2023 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
100000 usd
CY2024 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
40163000 usd
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
29080000 usd
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
59545000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24556000 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4735000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-471000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8436000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8907000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13171000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8436000 usd
CY2024 us-gaap Interest Paid Net
InterestPaidNet
10508000 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
1428000 usd
CY2024 us-gaap Income Taxes Paid
IncomeTaxesPaid
109000 usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
96000 usd
CY2024 pnst Interest Forfeit Long Term Debt
InterestForfeitLongTermDebt
890000 usd
CY2023 pnst Interest Forfeit Long Term Debt
InterestForfeitLongTermDebt
0 usd
CY2024 pnst Reclassification Of Warrant Liability
ReclassificationOfWarrantLiability
940000 usd
CY2023 pnst Reclassification Of Warrant Liability
ReclassificationOfWarrantLiability
0 usd
CY2024 pnst Noncash Merger Costs Incurred But Not Yet Paid
NoncashMergerCostsIncurredButNotYetPaid
-596000 usd
CY2023 pnst Noncash Merger Costs Incurred But Not Yet Paid
NoncashMergerCostsIncurredButNotYetPaid
0 usd
CY2024 pnst Adjustments To Additional Paid In Capital Transfer Of Warrants
AdjustmentsToAdditionalPaidInCapitalTransferOfWarrants
29824000 usd
CY2023 pnst Adjustments To Additional Paid In Capital Transfer Of Warrants
AdjustmentsToAdditionalPaidInCapitalTransferOfWarrants
0 usd
CY2024 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
14018000 usd
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
7580000 usd
CY2024 us-gaap Notes Assumed1
NotesAssumed1
2805000 usd
CY2023 us-gaap Notes Assumed1
NotesAssumed1
0 usd
CY2024 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
654000 usd
CY2023 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
9924000 usd
CY2024 us-gaap Preferred Stock Convertible Down Round Feature Increase Decrease In Equity Amount1
PreferredStockConvertibleDownRoundFeatureIncreaseDecreaseInEquityAmount1
-1423000 usd
CY2023 us-gaap Preferred Stock Convertible Down Round Feature Increase Decrease In Equity Amount1
PreferredStockConvertibleDownRoundFeatureIncreaseDecreaseInEquityAmount1
0 usd
CY2024 us-gaap Dividends Preferred Stock
DividendsPreferredStock
878000 usd
CY2023 us-gaap Dividends Preferred Stock
DividendsPreferredStock
0 usd
CY2024 us-gaap Nature Of Operations
NatureOfOperations
<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1 – Nature of Business and Basis of Presentation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pinstripes Holdings, Inc. (“Pinstripes”, “New Pinstripes”, the “Company”, “we”, “us”, or “our”) was formed for the purpose of operating and expanding a unique entertainment and dining concept. As of April 28, 2024, the Company has 17 locations in ten states and generates revenue primarily from the sale of food, beverages, bowling, bocce and hosting private events. The Company operates its business as one operating and one reportable segment.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 29, 2023, Pinstripes, Inc. (the “Predecessor” or “Legacy Pinstripes”) consummated the previously announced business combination pursuant to the Business Combination Agreement, dated as of June 22, 2023 (as amended and restated as of September 26, 2023 and November 22, 2023, the “BCA” or “Business Combination”), by and among Legacy Pinstripes, Banyan Acquisition Corporation, a </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Delaware corporation (“Banyan”), and Panther Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Banyan. The financial statements included in this report reflect (i) the historical operating results of Legacy Pinstripes prior to the Business Combination and (ii) the combined results of Legacy Pinstripes and New Pinstripes following the closing of the Business Combination (collectively, Legacy Pinstripes and New Pinstripes are referred to as the “Company”). In connection with the closing of the Business Combination, Banyan changed its name to Pinstripes Holdings, Inc. (see Note 3).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The closing of the Business Combination is accounted for as a reverse recapitalization. The prior period share and per share amounts presented in the consolidated financial statements and related notes have been retroactively adjusted to give effect to the reverse recapitalization treatment of the transactions completed by the Business Combination.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States for interim financial information as prescribed by the Securities and Exchange Commission (“SEC”).</span></div>
CY2024Q2 pnst Number Of Locations
NumberOfLocations
17 location
CY2024Q2 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
10 state
CY2024 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2024 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024 us-gaap Fiscal Period
FiscalPeriod
<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal years</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s fiscal year consists of 52/53-weeks ending on the last Sunday in April. The fiscal year ended April 30, 2023 contained 53 weeks and the fiscal year ended April 28, 2024 contained 52 weeks. In a 52-week fiscal year, the first, second and third fiscal quarters each contain twelve weeks and the fourth fiscal quarter contains sixteen weeks. In a 53-week fiscal year, the first, second and third fiscal quarters each contain twelve weeks and the fourth fiscal quarter contains seventeen weeks.</span></div>
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.</span></div>
CY2024Q2 us-gaap Credit And Debit Card Receivables At Carrying Value
CreditAndDebitCardReceivablesAtCarryingValue
1624000 usd
CY2023Q2 us-gaap Credit And Debit Card Receivables At Carrying Value
CreditAndDebitCardReceivablesAtCarryingValue
1381000 usd
CY2024Q2 us-gaap Restricted Cash
RestrictedCash
1000000 usd
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
0 usd
CY2024 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.006
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
2363000 usd
CY2024Q2 us-gaap Deposits
Deposits
6640000 usd
CY2023Q2 us-gaap Deposits
Deposits
5453000 usd
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.026
us-gaap Pre Opening Costs
PreOpeningCosts
8889000 usd
us-gaap Pre Opening Costs
PreOpeningCosts
4935000 usd
us-gaap Advertising Expense
AdvertisingExpense
5868000 usd
us-gaap Advertising Expense
AdvertisingExpense
3648000 usd
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P5Y
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.34
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
11089695 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
11089695 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
354436 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
354436 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17422009 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17422009 shares
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39918036 shares
CY2024 pnst Reverse Recapitalization Accrued Transaction Costs
ReverseRecapitalizationAccruedTransactionCosts
24317000 usd
CY2024 pnst Document Registration Statement Transaction Costs
DocumentRegistrationStatementTransactionCosts
635000 usd
CY2024Q2 pnst Reverse Recapitalization Transaction Costs Prepaid And Other Current Assets
ReverseRecapitalizationTransactionCostsPrepaidAndOtherCurrentAssets
940000 usd
CY2024 pnst Payments Of Reverse Recapitalization Transaction Costs
PaymentsOfReverseRecapitalizationTransactionCosts
23864000 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023 pnst Adjustments To Additional Paid In Capital Reverse Recapitalization
AdjustmentsToAdditionalPaidInCapitalReverseRecapitalization
61000 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Inventory Net
InventoryNet
949000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
802000 usd
CY2024Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
557000 usd
CY2024 pnst Effective Income Tax Rate Reconciliation Deferred Adjustments Amount
EffectiveIncomeTaxRateReconciliationDeferredAdjustmentsAmount
1558000 usd
CY2023 pnst Effective Income Tax Rate Reconciliation Deferred Adjustments Amount
EffectiveIncomeTaxRateReconciliationDeferredAdjustmentsAmount
0 usd
CY2024 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4672000 usd
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3010000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2241000 usd
CY2024Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
1566000 usd
CY2023Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
1072000 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
206000 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
924000 usd
CY2024Q2 pnst Landlord Advances Current
LandlordAdvancesCurrent
0 usd
CY2023Q2 pnst Landlord Advances Current
LandlordAdvancesCurrent
912000 usd
CY2024Q2 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
311000 usd
CY2023Q2 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
864000 usd
CY2024Q2 pnst Warrants And Rights Outstanding Current
WarrantsAndRightsOutstandingCurrent
1012000 usd
CY2023Q2 pnst Warrants And Rights Outstanding Current
WarrantsAndRightsOutstandingCurrent
0 usd
CY2024Q2 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
285000 usd
CY2023Q2 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
387000 usd
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
156000 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
288000 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6546000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6688000 usd
CY2024Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
35433000 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
6367000 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
75495000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
37255000 usd
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
4818000 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1044000 usd
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
70677000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
36211000 usd
CY2023Q1 pnst Debt Instrument Number Of Tranches
DebtInstrumentNumberOfTranches
2 tranche
CY2021Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0107
CY2024 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
5000 shares
CY2021Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0107
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4265000 usd
CY2024 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
78000 usd
CY2023 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
0 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
36000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
192000 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
4818000 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
7123000 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
10198000 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
34390000 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
75889000 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
500000 usd
CY2024Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
132918000 usd
CY2024 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
36000 usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
192000 usd
CY2024 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
36000 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
192000 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
36000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
192000 usd
CY2024 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1376000 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1540000 usd
CY2024 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
884000 usd
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-711000 usd
CY2024 pnst Effective Income Tax Rate Reconciliation Permanent Differences Amount
EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount
295000 usd
CY2023 pnst Effective Income Tax Rate Reconciliation Permanent Differences Amount
EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount
102000 usd
CY2024 pnst Effective Income Tax Rate Reconciliation Debt Forgiveness Cares Act Amount
EffectiveIncomeTaxRateReconciliationDebtForgivenessCARESActAmount
0 usd
CY2023 pnst Effective Income Tax Rate Reconciliation Debt Forgiveness Cares Act Amount
EffectiveIncomeTaxRateReconciliationDebtForgivenessCARESActAmount
-1755000 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
0 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-12000 usd
CY2024 pnst Effective Income Tax Rate Reconciliation Fair Market Value Adjustment Warrants Amount
EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustmentWarrantsAmount
5593000 usd
CY2023 pnst Effective Income Tax Rate Reconciliation Fair Market Value Adjustment Warrants Amount
EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustmentWarrantsAmount
0 usd
CY2024 pnst Effective Income Tax Rate Reconciliation Return To Provision Adjustment Amount
EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount
75000 usd
CY2023 pnst Effective Income Tax Rate Reconciliation Return To Provision Adjustment Amount
EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount
0 usd
CY2024 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
407000 usd
CY2023 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
157000 usd
CY2024Q2 pnst Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contract Liability
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContractLiability
550000 usd
CY2023Q2 pnst Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contract Liability
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContractLiability
1474000 usd
CY2024Q2 pnst Deferred Tax Assets Leasing Arrangements
DeferredTaxAssetsLeasingArrangements
29718000 usd
CY2023Q2 pnst Deferred Tax Assets Leasing Arrangements
DeferredTaxAssetsLeasingArrangements
28481000 usd
CY2024Q2 pnst Deferred Tax Assets Interest Expense
DeferredTaxAssetsInterestExpense
3059000 usd
CY2023Q2 pnst Deferred Tax Assets Interest Expense
DeferredTaxAssetsInterestExpense
1481000 usd
CY2024Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
20890000 usd
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
14961000 usd
CY2024Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
4735000 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
4328000 usd
CY2024Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
65000 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
97000 usd
CY2024Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
552000 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
271000 usd
CY2024Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3000 usd
CY2023Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3000 usd
CY2024Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
59572000 usd
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
51096000 usd
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
47693000 usd
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
43021000 usd
CY2024Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
11879000 usd
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
8075000 usd
CY2024Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2568000 usd
CY2023Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2597000 usd
CY2024Q2 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
9311000 usd
CY2023Q2 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
5478000 usd
CY2024Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
11879000 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
8075000 usd
CY2024Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0 usd
CY2023Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0 usd
CY2024Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
20890000 usd
CY2024 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
4672000 usd
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
4265000 usd
CY2023Q2 pnst Lessee Operating Lease Lease Abatement
LesseeOperatingLeaseLeaseAbatement
4673000 usd
CY2023Q2 us-gaap Accrued Rent Current And Noncurrent
AccruedRentCurrentAndNoncurrent
4500000 usd
CY2023Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
2678000 usd
CY2023Q2 pnst Increase Decrease In Occupancy Net
IncreaseDecreaseInOccupancyNet
-9173000 usd
CY2023Q2 pnst Gain Loss On Lease Modification
GainLossOnLeaseModification
3281000 usd
CY2024Q2 pnst Lessee Operating Lease Lease Not Yet Commenced Liability
LesseeOperatingLeaseLeaseNotYetCommencedLiability
81226000 usd
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
0
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.34
us-gaap Operating Lease Cost
OperatingLeaseCost
12980000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
14199000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
5936000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
3616000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
172000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
43000 usd
us-gaap Lease Cost
LeaseCost
19088000 usd
us-gaap Lease Cost
LeaseCost
17858000 usd
CY2024 us-gaap Operating Lease Expense
OperatingLeaseExpense
1418000 usd
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
1547000 usd
CY2024 us-gaap Operating Lease Payments
OperatingLeasePayments
28244000 usd
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
25549000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
25971000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
21858000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
21273000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
20289000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
16866000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
85939000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
192196000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
82682000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
109514000 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P12Y
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y9M18D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.117
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.095
CY2023Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
53468000 usd
CY2024 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
19843000 usd
CY2024 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
1423000 usd
CY2024 us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
878000 usd
CY2024 pnst Temporary Equity Conversion Of Stock Reverse Recapitalization
TemporaryEquityConversionOfStockReverseRecapitalization
75612000 usd
CY2024Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4223335000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5330
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y6M21D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
16628000 usd
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1605234000 shares
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
11.70
CY2024 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
47395000 shares
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.55
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
92000 usd
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
1089473000 shares
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
8.58
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4691701000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.76
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y5M4D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2495483000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.37
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y6M
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
6149000 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.66
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
483649 shares
CY2023Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.31
CY2024 pnst Class Of Warrant Or Right Granted
ClassOfWarrantOrRightGranted
28864100 shares
CY2024 pnst Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Granted
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsGranted
9.56
CY2024 pnst Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
0 shares
CY2024 pnst Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Expired
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExpired
0
CY2024 pnst Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
160149 shares
CY2024 pnst Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercised
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercised
0.01
CY2024 pnst Class Of Warrant Or Right Converted
ClassOfWarrantOrRightConverted
390100 shares
CY2024 pnst Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Converted
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsConverted
1.71
CY2024Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
28797500 shares
CY2024Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
9.58
us-gaap Net Income Loss
NetIncomeLoss
-6789000 usd
us-gaap Net Income Loss
NetIncomeLoss
-7525000 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
878000 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 usd
us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
1423000 usd
us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
0 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9090000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-9090000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7525000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-7525000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22317755 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11480322 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22317755 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11480322 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.66
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
CY2023Q4 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
464000 usd
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001852633-24-000036-index-headers.html Edgar Link pending
0001852633-24-000036-index.html Edgar Link pending
0001852633-24-000036.txt Edgar Link pending
0001852633-24-000036-xbrl.zip Edgar Link pending
a10-kex971xclawbackpolicy.htm Edgar Link pending
a10-kexhibit231xgtconsent.htm Edgar Link pending
a10-kexhibit232xeyconsent.htm Edgar Link pending
a10-kexhibit311.htm Edgar Link pending
a10-kexhibit312.htm Edgar Link pending
a10-kexhibit321.htm Edgar Link pending
a10-kexhibit322.htm Edgar Link pending
aex43xdescriptionofsecurit.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_0a.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
pnst-20240428.htm Edgar Link pending
pnst-20240428.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
pnst-20240428_cal.xml Edgar Link unprocessable
pnst-20240428_def.xml Edgar Link unprocessable
pnst-20240428_pre.xml Edgar Link unprocessable
pnst-20240428_htm.xml Edgar Link completed
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pnst-20240428_lab.xml Edgar Link unprocessable